GI & Endoscopy

Corticosteroid use is associated with a nearly five-fold increase of venous thromboembolism in inflammatory bowel disease patients as compared to treatment with only a biologic agent, according to a new study in Clinical Gastroenterology and Hepatology.

Here is a stock report on five publicly traded GI/endoscopy companies for Jan. 26 to Jan. 30.

Here are six gastroenterologists who made headlines with leadership moves and honorable recognitions within the past week.

Consolidation in medicine is an extensive trend. Will gastroenterology practices be swept along with the tide of physician groups seeking strength in numbers? Two practicing GI physicians weigh in on whether or not mergers will be a big trend in…

When we take on a new physician client, including a gastroenterologist, we often find that they have received little advice or direction from their CPAs in the area of asset protection. As a CPA with over 20 years of experience…

Gastroenterologists, like all physicians, are focused on patient care in their specialty, from inflammatory bowel disease and Barrett's esophagus to colorectal cancer screening and liver disease. Here are eight gastroenterologists who have invented devices and treatments applicable to their field…

Brett Bernstein, MD, is the director of endoscopy, division of digestive diseases at Mount Sinai Beth Israel in New York. He is also the medical director of Eastside Endoscopy in New York. Additionally, he is the chief quality officer for…

Here are six recent must-reads on gastroesophageal reflux disease.

Continental Who's Who, a publisher of business leader biographies, has named gastroenterologist Douglas M. Weissman, MD, FACP, its 2014 to 2015 Prominent Physician of the Year.

Norton Healthcare, based in Louisville, Ky., has become the first Kentucky healthcare system to offer the non-invasive stool-based colorectal cancer screening test Cologuard, according to a WHAS 11 abc news report.